Galectin-3 as a potential biomarker of metabolic disorders and cardiovascular remodeling in patients with hypertension and type 2 diabetes

Thumbnail Image

Date

2017

Authors

Bobronnikova, Lesya

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

To determine the impact of galectin-3 levels on the progression of metabolic disorders and structural-functional changes in the myocardium and blood vessels in patients with concomitant systemic arterial hypertension (AH) and type 2 diabetes mellitus (type 2 DM).

Description

Keywords

arterial hypertension, type 2 diabetes, insulin resistance, cardiovascular remodeling, galectin-3

Citation

Bobronnikova L. R. Galectin-3 as a potential biomarker of metabolic disorders and cardiovascular remodeling in patients with hypertension and type 2 diabetes / L. R. Bobronnikova // Vessel Plus. – 2017. – № 1. – Р. 61–67. – DOI: 10.20517/2574-1209.2016.10.

Endorsement

Review

Supplemented By

Referenced By